• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞍旁肿瘤的组织病理学。

Histopathology of Parasellar Neoplasms.

机构信息

Institute of Pathology, School of Medicine, University of Belgrade, Belgrade, Serbia.

Section of Neurosurgery, Department of Neuroscience, Uppsala University, Uppsala, Sweden.

出版信息

Neuroendocrinology. 2020;110(9-10):740-752. doi: 10.1159/000507084. Epub 2020 Mar 11.

DOI:10.1159/000507084
PMID:32155632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7490502/
Abstract

The anatomical and histological complexity of the parasellar region as well as the presence of embryonic remnants determine the huge diversity of parasellar neoplasms. Some of them are only located in the parasellar region, whereas others can occur elsewhere, within or outside the central nervous system. Their spectrum ranges from histologically benign and low-grade malignant to high-grade malignant tumours. Although rare, metastases can pose differential diagnostic dilemmas. The severity of the clinical picture, the challenges of surgery and the risk of adverse sequelae related to surgery or radiotherapy make parasellar tumours interesting entities for the clinicians irrespective of their histological malignancy grade. Due to the different cell origins of parasellar tumours, the World Health Organization classification system does not categorise them as a distinct group. Detailed criteria for classification and malignancy grading are presented in the classification systems covering central nervous system tumours, haematological malignancies and tumours of the soft tissue and bone. In the last few years, molecular genetic features have been integrated into the diagnosis of several types of the parasellar tumours enhancing diagnostic accuracy and providing information of the value for targeting therapies. In this review, we will present histopathological and molecular genetic features, updated classification criteria and recent advances in the diagnostics and rationale for novel pharmacological therapies of selected types of parasellar neoplasms.

摘要

鞍旁区域的解剖学和组织学复杂性以及胚胎残留物的存在决定了鞍旁肿瘤的巨大多样性。其中一些仅位于鞍旁区域,而另一些则可能位于中枢神经系统内或外部的其他部位。它们的范围从组织学上良性和低度恶性到高度恶性肿瘤。尽管罕见,但转移瘤可能会造成鉴别诊断上的困境。临床症状的严重程度、手术的挑战以及与手术或放疗相关的不良后果风险,使得鞍旁肿瘤成为临床医生感兴趣的实体,无论其组织学恶性程度如何。由于鞍旁肿瘤的不同细胞起源,世界卫生组织分类系统并未将它们归为一个单独的组别。中枢神经系统肿瘤、血液系统恶性肿瘤以及软组织和骨肿瘤的分类系统中详细列出了分类和恶性分级的标准。在过去的几年中,分子遗传学特征已被纳入几种鞍旁肿瘤的诊断中,提高了诊断的准确性,并提供了靶向治疗有价值的信息。在这篇综述中,我们将介绍鞍旁肿瘤的组织病理学和分子遗传学特征、更新的分类标准以及在选定类型的鞍旁肿瘤的诊断和新型药理学治疗方法的最新进展。

相似文献

1
Histopathology of Parasellar Neoplasms.鞍旁肿瘤的组织病理学。
Neuroendocrinology. 2020;110(9-10):740-752. doi: 10.1159/000507084. Epub 2020 Mar 11.
2
Diagnosis and Treatment of Parasellar Lesions.鞍旁病变的诊断与治疗。
Neuroendocrinology. 2020;110(9-10):728-739. doi: 10.1159/000506905. Epub 2020 Mar 4.
3
Imaging of suprasellar and parasellar tumors.鞍上及鞍旁肿瘤的影像学检查
Neuroimaging Clin N Am. 1999 Nov;9(4):717-32.
4
The diagnosis and management of parasellar tumours of the pituitary.垂体鞍旁肿瘤的诊断与管理
Endocr Relat Cancer. 2008 Dec;15(4):885-903. doi: 10.1677/ERC-08-0170. Epub 2008 Sep 22.
5
Inter-dural approach to parasellar tumors.鞍旁肿瘤的硬脑膜间入路。
Acta Neurochir (Wien). 2010 Feb;152(2):279-84; discussion 284-5. doi: 10.1007/s00701-009-0515-y. Epub 2009 Oct 14.
6
Radiotherapy of Parasellar Tumours.鞍旁肿瘤的放射治疗。
Neuroendocrinology. 2020;110(9-10):848-858. doi: 10.1159/000506902. Epub 2020 Mar 4.
7
The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.2016 年版世界卫生组织中枢神经系统肿瘤分类:对弥漫性神经胶质瘤队列的回顾性应用。
J Neurooncol. 2018 Mar;137(1):181-189. doi: 10.1007/s11060-017-2710-7. Epub 2017 Dec 7.
8
Benign brain tumors: sellar/parasellar tumors.良性脑肿瘤:鞍区/鞍旁肿瘤。
Neurol Clin. 2007 Nov;25(4):1231-49, xi. doi: 10.1016/j.ncl.2007.07.003.
9
The sympathetic nerves of the parasellar region: pathways to the orbit and the brain.鞍旁区域的交感神经:通往眼眶和大脑的路径。
Acta Anat (Basel). 1997;160(4):254-60. doi: 10.1159/000148019.
10
The radiological changes and clinical incidence of endocrine effects in sellar and parasellar tumours.鞍区及鞍旁肿瘤的放射学改变及内分泌效应的临床发生率。
Radiology. 1960 Dec;75:877-84. doi: 10.1148/75.6.877.

引用本文的文献

1
Clinical Characteristics and Prognostic Risk Factors of Parasellar Chondrosarcoma.鞍旁软骨肉瘤的临床特征及预后危险因素
Brain Sci. 2022 Oct 6;12(10):1353. doi: 10.3390/brainsci12101353.
2
Case Report: Malignant Primary Sellar Paraganglioma With Unusual Genetic and Imaging Features.病例报告:具有不寻常遗传和影像学特征的原发性鞍区副神经节瘤
Front Oncol. 2021 Nov 23;11:739255. doi: 10.3389/fonc.2021.739255. eCollection 2021.
3
Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification.垂体神经内分泌肿瘤:神经内分泌肿瘤分类的模型。
Mod Pathol. 2021 Sep;34(9):1634-1650. doi: 10.1038/s41379-021-00820-y. Epub 2021 May 21.

本文引用的文献

1
Genetic and immune profiling for potential therapeutic targets in adult human craniopharyngioma.成人颅咽管瘤潜在治疗靶点的基因和免疫分析
Clin Oncol Res. 2019;2(3):2-8. doi: 10.31487/j.COR.2019.03.05. Epub 2019 Jun 27.
2
Dual BRAF/MEK therapy in BRAF V600E-mutated primary brain tumors: a case series showing dramatic clinical and radiographic responses and a reduction in cutaneous toxicity.BRAF V600E 突变原发性脑肿瘤的双 BRAF/MEK 疗法:一个病例系列显示出显著的临床和影像学反应以及皮肤毒性降低。
J Neurosurg. 2019 Nov 1;133(6):1704-1709. doi: 10.3171/2019.8.JNS19643. Print 2020 Dec 1.
3
Newly diagnosed papillary craniopharyngioma with mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report.新诊断的伴有突变的乳头状颅咽管瘤采用单药选择性BRAF抑制剂达拉非尼治疗:一例报告
Oncotarget. 2019 Oct 15;10(57):6038-6042. doi: 10.18632/oncotarget.27203.
4
Peculiar pathological, radiological and clinical features of skull-base de-differentiated chordomas. Results from a referral centre case-series and literature review.颅底去分化脊索瘤的特殊病理、放射学和临床特征。来自转诊中心病例系列和文献复习的结果。
Histopathology. 2020 Apr;76(5):731-739. doi: 10.1111/his.14024. Epub 2020 Mar 10.
5
Systematic Review of Clinical, Radiologic, and Histologic Features of Benign Notochordal Cell Tumors: Implications for Patient Management.良性脊索细胞肿瘤的临床、放射学和组织学特征的系统评价:对患者管理的影响。
World Neurosurg. 2019 Oct;130:13-23. doi: 10.1016/j.wneu.2019.06.009. Epub 2019 Jun 14.
6
Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT Consortium.190 例中枢神经系统生殖细胞瘤的临床、组织病理学和分子数据的综合分析,来自 iGCT 联盟。
Neuro Oncol. 2019 Dec 17;21(12):1565-1577. doi: 10.1093/neuonc/noz139.
7
Pheochromocytoma and Paraganglioma.嗜铬细胞瘤和副神经节瘤。
N Engl J Med. 2019 Aug 8;381(6):552-565. doi: 10.1056/NEJMra1806651.
8
The Medical Therapy of Craniopharyngiomas: The Way Ahead.颅咽管瘤的医学治疗:未来之路。
J Clin Endocrinol Metab. 2019 Dec 1;104(12):5751-5764. doi: 10.1210/jc.2019-01299.
9
Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations.靶向治疗携带 BRAF V600E 突变的颅咽管瘤。
Cancer. 2019 Sep 1;125(17):2910-2914. doi: 10.1002/cncr.32197. Epub 2019 Jul 17.
10
Pituitary Metastases: A Nationwide Study on Current Characteristics With Special Reference to Breast Cancer.垂体转移瘤:一项关于当前特征的全国性研究,特别参考了乳腺癌。
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3379-3388. doi: 10.1210/jc.2019-00012.